Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STABLE: Gemigliptin Combination Therapy in T2DM
NCT01890629Phase 4Completed
- Sponsor
- LG Chem
- Start
- May 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of gemigliptin in type 2 diabetes mellitus (T2DM), sponsored by LG Chem. Started May 2013; status: completed.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01890629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01890629.